• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ALK-Abello A/S

+ Add to Watchlist

AKBLF:US

113.0000 USD 29.4190 20.66%

As of 20:10:04 ET on 12/11/2014.

Snapshot for ALK-Abello A/S (AKBLF)

Open: 113.0000 Day's Range: 113.0000 - 113.0000 Volume: 82
Previous Close: 142.4190 52wk Range: 113.0000 - 144.7500 1-Yr Rtn: -

Stock Chart for AKBLF

No chart data available.
  • AKBLF:US 113.0000
  • 1M
  • 1Y
142.4190
Interactive AKBLF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKBLF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 32.3114
Relative P/E vs. SPX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2014) 21.2540
Est. PEG Ratio -
Market Cap (M USD) 1,102.24
Shares Outstanding (M) 9.21
30 Day Average Volume 3
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.82%
Cash Dividend (DKK) 5.0000
Dividend Ex-Date 03/13/2014
5 Year Dividend Growth 0.99%
Next Earnings Announcement 02/09/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKBLF

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for AKBLF

Alk-Abello A/S produces pharmaceuticals for allergy vaccination. The Company is an international group with subsidiaries and associated companies worldwide.

Jens BagerPresident/CEOSoren NiegelExec VP:Commercial Operations
Flemming PedersenExec VP:Finance & IT/CFOHelle SkovExec VP:Product Supply
More Company Profile & Key Executives for AKBLF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil